As show in Fig. 6D/E, SeC administration in vivo significantly inhibited the cell proliferation (Ki-67 staining), suppressed the tumor angiogenesis (CD-31 staining) and induced apoptosis (caspase-3 activation). The gene discussed is CASP3; the disease is neoplasm.